Silver Book Fact

An increase in bone mineral density (BMD) testing and osteoporosis treatment was associated with a decrease in hip fracture incidence.

Jaglal, Susan B., Ian Weller, Muhammad Mamdani, Gillian Hawker, Hans Kreder, Liisa Jaakkimainen, and Jonathan Adachi. Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the hip fracture projections wrong?. Arch Intern Med. 2005; 159(11): 1215-20. http://www.ncbi.nlm.nih.gov/pubmed/15883628

Reference

Title
Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the hip fracture projections wrong?
Publication
Arch Intern Med
Publication Date
2005
Authors
Jaglal, Susan B., Ian Weller, Muhammad Mamdani, Gillian Hawker, Hans Kreder, Liisa Jaakkimainen, and Jonathan Adachi
Volume & Issue
Volume 159, Issue 11
Pages
1215-20
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Alendronate, a bisphosphonate, has been shown to increase vertebral bone mineral density (BMD) by as much as 8% over 3-years in postmenopausal women with osteoporosis.  
  • Patients with vertebral fractures who underwent kyphoplasty, a procedure that stabilizes fractures of the spine, were found in one study to have reduced pain, fewer new fractures, and less healthcare…  
  • Clinical studies in nutrition and physical activity interventions have proven that fractures can be prevented, even in older individuals, and that they do not need to be a natural consequence…  
  • Risedronate, a bisphosphonate, has been shown to reduce vertebral fractures by around 41%, hip fractures by 30%, and non-vertebral fractures by 39%.  
  • A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.